DISCOUNT ZERTIFIKAT - STRYKER CORP. Share Price

Certificat

DE000ME7GM45

Real-time Bid/Ask 07:49:40 06/06/2024 pm IST
270.52 EUR / 270.71 EUR -0.05% Intraday chart for DISCOUNT ZERTIFIKAT - STRYKER CORP.
Current month+0.20%
1 month+0.79%
Date Price Change
06/24/06 270.4 -0.13%
05/24/05 270.8 +0.30%
04/24/04 270 +0.23%
03/24/03 269.3 -0.33%
31/24/31 270.2 -0.08%

Delayed Quote Börse Stuttgart

Last update June 06, 2024 at 05:49 pm IST

More quotes

Static data

Product typeCertificados de Descuento
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME7GM4
ISINDE000ME7GM45
Date issued 24/01/2024
Maturity 20/09/2024 (106 Days)
Parity 1 : 1
Emission price 259.6
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 271.6
Lowest since issue 254.3
Spread 0.13
Spread %0.05%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
346 USD
Average target price
373.1 USD
Spread / Average Target
+7.83%
Consensus